Andrew Cook

This inventor holds 22 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Constellation Pharmaceuticals, Inc., Eisai R&d Management Co., Ltd., Axovant Sciences Gmbh. Active years: 2015-2026.

USPTO Granted Patents = 22 (Patent Applications = 7)

% Patents Active = 59.1

EPO Patents = 1 (Patent Applications = 6)

Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 41(Granted Patents)

Location History:

Jackson, MI (US) (2015)
Fort Erie, CA (2021)
Stow, MA (US) (2015 - 2024)

Company Filing History:

6 out of 56

Constellation Pharmaceuticals, Inc.

patents

6 out of 530

Eisai R&d Management Co., Ltd.

patents

3 out of 8

Axovant Sciences Gmbh

patents

4. 2 out of 13

Eisai R&D Management Co., Ltd.

patents

5. 1 out of 56

Denali Therapeutics Inc.

patents

6. 4 out of 834,307

Other

patents

Years Active: 2015-2026

Loading Chart...

22 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12622905 - ARYL PLADIENOLIDES FOR THE TREATMENT OF NEOPLASTIC DISORDERS (2026-05-12),

2. 12606541 - PPARg modulators and methods of use (2026-04-21),

3. 12514926 - SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE (2026-01-06),

4. 12172986 - Splicing modulator antibody-drug conjugates and methods of use (2024-12-24),

5. 11945807 - Splicing modulator antibody-drug conjugates and methods of use (2024-04-02),

6. 11926619 - Certain pladienolide compounds and methods of use (2024-03-12),

7. 11679107 - Certain aryl pladienolide compounds and methods of use (2023-06-20),

8. 11352348 - Splicing modulator antibody-drug conjugates and methods of use (2022-06-07),

9. 11084188 - Three-dimensional structure and method and system of making same (2021-08-10),

10. 11008755 - Ceiling system and hanger for suspending ceiling tiles or panels therefrom (2021-05-18),

11. 10941569 - Clip hanger and ceiling suspension system incorporating same (2021-03-09),

12. 10428062 - Geminal substituted aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors (2019-10-01),

13. 10370370 - Aminobenzisoxazole compounds as agonists of α7-nicotinic acetylcholine receptors (2019-08-06),

14. 10183938 - Geminal substituted quinuclidine amide compounds as agonists of α-7 nicotonic acetylcholine receptors (2019-01-22),

15. 10016405 - Modulators of methyl modifying enzymes, compositions and uses thereof (2018-07-10),

Certainly! Here is an article about inventor Andrew Cook:

Title: Unveiling the Inventive Mind of Andrew Cook

Introduction:

Andrew Cook, a prolific inventor hailing from Stow, MA (US), has made significant contributions to the field of oncology through his innovative patents and groundbreaking research. With an impressive portfolio of 14 patents, Andrew Cook continues to revolutionize the landscape of cancer therapeutics.

Latest Patents:

Andrew Cook's latest patents include the development of Splicing Modulator Antibody-Drug Conjugates and novel Pladienolide compounds. These cutting-edge inventions focus on enhancing the efficacy of cancer treatments by targeting human oncology targets and utilizing splicing modulator drug moieties.

Career Highlights:

Throughout his career, Andrew Cook has been associated with reputable companies such as Constellation Pharmaceuticals, Inc. and Eisai R&D Management Co., Ltd. He has spearheaded research projects aimed at advancing the forefront of oncology treatments and has been instrumental in translating scientific discoveries into practical applications.

Collaborations:

Andrew Cook has had the pleasure of working alongside esteemed colleagues such as Brian K Albrecht and James E Audia. Their collaborative efforts have resulted in the development of innovative therapeutic strategies and have laid the foundation for future advancements in the field of cancer research.

Conclusion:

In conclusion, Andrew Cook's relentless pursuit of innovation and his unwavering dedication to improving cancer therapeutics have solidified his position as a trailblazer in the realm of oncology. His pioneering patents and collaborative endeavors underscore his commitment to driving progress and delivering impactful solutions to combat neoplastic disorders.Dot

Let me know if you need more information or if there is anything else I can assist you with.